← Back to Search

Exercise for Breast Cancer Cognitive Function (BRAIN Trial)

N/A

Waitlist Available

Led By Diane K. Ehlers, Ph.D.

Research Sponsored by University of Nebraska

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

First, primary diagnosis of Stage I-IIIa breast cancer

Post-menopausal at diagnosis (no menses for 12 mo.)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (month 0), post-intervention (month 6), follow up (month 12)

Awards & highlights

BRAIN Trial Summary

This trial will test if exercise can improve cognitive function in post-menopause breast cancer survivors.

Who is the study for?

This trial is for post-menopausal women who had a first, primary diagnosis of Stage I-IIIa breast cancer, are sedentary, and have completed their main treatments between 3-24 months ago. They must be cleared by a physician to exercise and agree to randomization. Excluded are those with second cancer diagnoses (except certain skin cancers), significant cognitive impairment, recent or ongoing chemotherapy or radiation therapy, neurological disorders, planned surgeries during the study period, or contraindications to MRI.Check my eligibility

What is being tested?

The study aims to see if aerobic exercise training improves cognitive function in these survivors compared to health education. Participants will either join an exercise program or receive health education as an active comparator. The effectiveness of the interventions will be measured through changes in cognitive function.See study design

What are the potential side effects?

While not explicitly listed in the provided information, potential side effects from participating could include typical risks associated with starting an exercise regimen such as muscle soreness, fatigue, and increased risk of injury.

BRAIN Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My first cancer diagnosis is Stage I-IIIa breast cancer.

Select...

I have been post-menopausal since my diagnosis.

Select...

I was post-menopausal when my cancer was diagnosed.

BRAIN Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (month 0), post-intervention (month 6), follow up (month 12)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (month 0), post-intervention (month 6), follow up (month 12)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (month 0), post-intervention (month 6), follow up (month 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in brain volume

Change in cognitive flexibility

Change in executive function processing

+9 more

Secondary outcome measures

Adoption

Implementation

Maintenance

+1 more

Other outcome measures

Change in Cancer-related Fatigue

Change in Cardiorespiratory Fitness

BRAIN Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Aerobic Exercise TrainingExperimental Treatment3 Interventions

Breast cancer survivors randomized to the intervention group will participate in a moderate-intensity aerobic exercise program for 24 weeks.

Group II: Health Education (Control)Active Control3 Interventions

Individuals randomized to Health Education will receive individual education and counseling related to general cancer-related health and support across 24 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Magnetic Resonance Imaging

2017

Completed Phase 3

~1190

Aerobic Exercise Training

2020

Completed Phase 4

~5450